menu
    • menu

    Company profile for Flugen

    NEW Drugs in Dev: 4
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    FLUGEN INC is a biotechnology company based out of 597 SCIENCE DR , MADISON, Wisconsin, United States.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FlugenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    597 Science Drive, Madison, WI 53711
    Telephone
    Telephone
    608-441-2729
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://flugen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FluGen's M2SR Vaccine Shows Superiority When Combined With High Dose Shot
    FluGen's M2SR Vaccine Shows Superiority When Combined With High Dose Shot

    12 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/12/2912327/0/en/FluGen-s-Intranasal-M2SR-Flu-Vaccine-Co-Administered-with-High-Dose-Vaccine-in-Older-Adults-Shows-Superiority-Over-Flu-Shot-Alone.html

    GLOBENEWSWIRE
    12 Jul 2024
    Share Share
    FluGen Announces Completion of 1st Cohort in Age De-escalation Trial of M2SR
    FluGen Announces Completion of 1st Cohort in Age De-escalation Trial of M2SR

    07 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/flugen-announces-completion-of-first-cohort-in-age-de-escalation-clinical-trial-of-m2sr-flu-vaccine-candidate-in-pediatric-subjects-ages-6-months-to-17-years-301616096.html

    PRNEWSWIRE
    07 Sep 2022
    Share Share
    FluGen Begins Dosing in PIb Trial of its Intranasal M2SR Flu Vaccine
    FluGen Begins Dosing in PIb Trial of its Intranasal M2SR Flu Vaccine

    22 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/flugen-announces-first-subject-dosed-in-phase-1b-clinical-trial-of-its-intranasal-m2sr-flu-vaccine-co-administered-with-high-dose-vaccine-in-older-adults-301572735.html

    PRNEWSWIRE
    22 Jun 2022
    Share Share
    Naobios manufactures FluGen’s M2SR influenza vaccine
    Naobios manufactures FluGen’s M2SR influenza vaccine

    21 Sep 2021

    // PHARMBIWEB

    https://www.pharmiweb.com/press-release/2021-09-21/naobios-manufactures-flugen-inc-s-m2sr-influenza-vaccine-candidate-for-upcoming-clinical-trials

    PHARMBIWEB
    21 Sep 2021
    Share Share
    FluGen Awarded US DOD Fund to Study M2SR Flu Vaccine
    FluGen Awarded US DOD Fund to Study M2SR Flu Vaccine

    01 Jul 2021

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flugen-awarded-us-department-of-defense-funding-to-conduct-clinical-study-evaluating-investigational-m2sr-flu-vaccine-and-current-standard-of-care-high-dose-vaccine-301323692.html

    PR NEWSWIRE
    01 Jul 2021
    Share Share
    FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine;1st Study in Adults Age 85
    FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine;1st Study in Adults Age 85

    25 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/flugen-initiates-nih-funded-trial-of-m2sr-flu-vaccine-first-study-in-adults-up-to-age-85-301298147.html

    PRNEWSWIRE
    25 May 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search